Biotech · Private company
Dragonfly Therapeutics
Track this companyFree. Adds Dragonfly Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- DF1001Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- DF9001Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- KEYTRUDA® (pembrolizumab)Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Nab paclitaxelPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Sacituzumab Govitecan-hziyPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- DF6002Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DF6215Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- KEYTRUDA®Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of DF6215 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Nov 28, 2023ClinicalTrials.gov NCT06108479 · fetched Nov 12, 2026
- Study of DF9001 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Nov 15, 2022ClinicalTrials.gov NCT05597839 · fetched Nov 12, 2026
- A Study of DF6002 Alone and in Combination With NivolumabPHASE1 · COMPLETED · started Jul 13, 2020ClinicalTrials.gov NCT04423029 · fetched Nov 12, 2026
- Study of DF1001 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Nov 11, 2019ClinicalTrials.gov NCT04143711 · fetched Nov 12, 2026